The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro
(Q41089018)
scientific article published on January 1, 1992
scientific article published on January 1, 1992
Language: